메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

논문 기본 정보

자료유형
학술저널
저자정보
Bong-Keun Jang (JBK-LAB) Hye-Yeon Kang (JBK-LAB) Sunyoung Park (JBK-LAB) Gun-Woo Lee (JBK-LAB) Youngsun Kwon (JBK-LAB) Sang-Eun Shin (JBK-LAB)
저널정보
세포교정의약학회 셀메드 셀메드 제14권 제14호
발행연도
2024.11
수록면
28 - 34 (7page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
Influenza is an infectious disease which accompanies systematic inflammation. Although eliminating the primary or secondary infectious agent is an important action in treating influenza, it is still difficult because not only mutations of viruses but also antibiotics-resistance of bacteria. Eunkyosan, is traditionally used herbal formula to symptoms of influenza, have were reported for its pharmacological properties on inflammation. Also, Alginate, a physiologically active acidic polysaccharide obtained from brown algae, alleviates inflammation, exhibits anti-bacterial properties, and shows a collaborative therapeutic effect with an anti-bacterial agent for acute infections. Thus, we investigated anti-inflammatory effects of Lorafocin (a mixture of Eunkyosan and alginate) against lipopolysaccharide (LPS)-induced inflammation in RAW 264.7 macrophage cell line and its underlying mechanisms as well as anti-bacterial effects. In the RAW 264.7 macrophage cell line, Lorafocin treatment reduced the secretion of inflammatory mediators such as nitric oxide (NO) and pro-inflammatory cytokines induced by LPS. To elucidate the anti-inflammatory mechanism of Lorafocin, we investigated the involvement of the mitogen-activated protein kinase (MAPK) and protein kinase B (Akt) signaling pathway. Studies demonstrated that Lorafocin exhibited anti- inflammatory efficacy by regulating Akt, c-Jun N-terminal kinase/stress-activated protein kinase (JNK), and extracellular signal-regulated kinase (ERK) 1/2 in LPS-induced RAW264.7 macrophages. Furthermore, Lorafocin inhibited the bacterial growth of Staphylococcus aureus and Escherichia coli. Taken together, Lorafocin may possess the capability to effectively modulate inflammatory responses and inhibit the growth of pathogenic bacteria.

목차

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULT
DISCUSSION
REFERENCES

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-151-25-02-091201507